Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Kamada Ltd changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 5.78M | 5.67M | −106.7K (−1.8%) |
| Value | $36.9M | $31.9M | −$4.96M (−13.5%) |
New holders (2)
Institutions that held Kamada Ltd at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 340 | $1.91K | 0.00% |
| Citigroup Inc | 300 | $1.70K | 0.00% |
Sold out (3)
Institutions that held Kamada Ltd at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Calton & Associates, Inc. | 18,124 | $110.9K |
| Walleye Capital LLC | 11,743 | $71.9K |
| GWM Advisors LLC | 2,724 | $16.7K |